Skip to main content

Medical Oncology

Ausgabe 2/2014

Inhalt (23 Artikel)

Original Paper

Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma

Yaoyao Su, Lihong Yin, Ran Liu, JingYi Sheng, Miao Yang, Yi Wang, Enchun Pan, Wei Guo, Yuepu Pu, Juan Zhang, Geyu Liang

Original Paper

Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis

Sanaa Eissa, Marwa Matboli, Amal Mansour, Shimaa Mohamed, Nahla Awad, Youssef M. Kotb

Original Paper

Txr1: an important factor in oxaliplatin resistance in gastric cancer

Jingtao Bi, Zhigang Bai, Xuemei Ma, Jianning Song, Yantong Guo, Jingming Zhao, Xin Yi, Shiwei Han, Zhongtao Zhang

Original Paper

High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma

Ping Sui, Pingping Hu, Tiehong Zhang, Xiangwei Zhang, Qi Liu, Jiajun Du

Original Paper

Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues

Narges Ahani, Mohsen Karimi Arzenani, Reza Shirkoohi, Mohammad Rokouei, Majid Alipour Eskandani, Abbas Nikravesh

Original Paper

A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1

Yichao Yan, Zhanlong Shen, Yingjiang Ye, Kewei Jiang, Hui Zhang, Chao Shen, Harri Mustonen, Pauli Puolakkainen, Shan Wang

Open Access Original Paper

The significance of LRPPRC overexpression in gastric cancer

Xiaosa Li, Lifen Lv, Jianyong Zheng, Jinfeng Zhou, Bing Liu, Hui Chen, Cong Liang, Rui Wang, Linna Su, Xiaohua Li, Daiming Fan

Original Paper

The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer

Marina Petrović, Zoran Bukumirić, Vladimir Zdravković, Slobodanka Mitrović, Henry Dushan Atkinson, Vladimir Jurišić

Original Paper

Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment

Olfa Baroudi, Thouraya Baroudi, Ines Omrane, Amel Moussa, Amel Mezlini, Hajer Ayari, Sami Guermazi, Abdesslem Bahloul, Hassen Bouzaienne, Nancy Uhrhammer, Yves Jean Bignon, Amel Benammar El-Gaaied, Karim Bougatef

Original Paper

Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative study

Haiyong Gu, Xu Wang, Liang Zheng, Weifeng Tang, Changqing Dong, Liming Wang, Yijun Shi, Aizhong Shao, Guowen Ding, Chao Liu, Ruiping Liu, Suocheng Chen, Jun Yin

Original Paper

Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele

Evgeny N. Suspitsin, Grigory A. Yanus, Anna P. Sokolenko, Olga S. Yatsuk, Olga A. Zaitseva, Alexandr A. Bessonov, Alexandr O. Ivantsov, Valeria A. Heinstein, Valery F. Klimashevskiy, Alexandr V. Togo, Evgeny N. Imyanitov

Original Paper

Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer

Hao Zhang, Yongchun Song, Peng Xia, Yao Cheng, Qi Guo, Dongmei Diao, Wei Wang, Xuandi Wu, Di Liu, Chengxue Dang

Original Paper

Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery

Moses Tam, Ashwatha Narayana, Shahzad Raza, Saroj Kunnakkat, John G. Golfinos, Erik C. Parker, Yelena Novik

Original Paper

Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase 99mTc-MIBI SPECT/CT

Chengrun Du, Hongmei Ying, Junjun Zhou, Jinjin Jiang, Chang Liu, Jingyi Chen, Xiaosheng Wang, Chaosu Hu

Original Paper

Hypofractionation and concomitant boost to deliver adjuvant whole-breast radiation in ductal carcinoma in situ (DCIS): a subgroup analysis of a prospective case series

Domenico Cante, Pierfrancesco Franco, Piera Sciacero, Giuseppe Girelli, Anna Maria Marra, Massimo Pasquino, Giuliana Russo, Valeria Casanova Borca, Guido Mondini, Ovidio Paino, Gianmauro Numico, Santi Tofani, Maria Rosa La Porta, Umberto Ricardi

Review Article

Triple-negative breast cancer: future prospects in diagnosis and management

Shereef Elsamany, Sakher Abdullah

Letter to the Editor

Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer

Mehmet Ali Nahit Şendur, Sercan Aksoy, Ozan Yazıcı, Nuriye Y. Ozdemir, Nurullah Zengin, Kadri Altundag

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.